Turn this list into an evaluation

Each entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.

Prepare with a buyer guide:

Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families

FDA-cleared K261405

ANDI 2.2

Imeka Solutions, Inc.

Authorized purpose: ANDI 2.2 processes brain MR images for atlas-assisted visualization, segmentation and volumetric quantification, presenting adjunctive DICOM-readable information for trained medical professionals; it does not predict, diagnose or interpret brain health.

Modality
MRI
Anatomy
Brain
Decision
2026-05-28
FDA-cleared K260032

Morph

BeauBrain Healthcare, Inc.

Authorized purpose: Morph automatically labels, visualizes, and volumetrically quantifies segmentable brain structures from MR images and may compare measurements with reference percentile data; it is adjunctive and not the sole basis for final decisions.

Modality
MRI
Anatomy
Brain
Decision
2026-05-13
FDA-cleared K253057

AI-Rad Companion Brain MR

Siemens Healthcare GmbH

Authorized purpose: Brain MRI morphometry and white matter hyperintensity quantification, including normative comparison and longitudinal change assessment for clinician review.

Modality
MRI
Anatomy
Brain
Decision
2026-01-22
FDA-cleared K253489

Swoop® Portable MR Imaging® System

Hyperfine, Inc.

Authorized purpose: Swoop Portable MR Imaging System provides ultra-low-field point-of-care head MRI for all ages and includes deep-learning T1, T2, FLAIR, and DWI reconstruction.

Modality
MRI
Anatomy
Brain
Decision
2025-12-12
FDA-cleared K252298

ANDI 2.0

Imeka Solutions, Inc.

Authorized purpose: Adjunctive quantitative brain MRI analysis that compares patient measures with normative and longitudinal references; a physician reviews all results and makes the clinical decision.

Modality
MRI
Anatomy
Brain
Decision
2025-10-22
FDA-cleared K251483

SwiftSight-Brain

AIRS Medical Inc.

Authorized purpose: Adjunctive brain MRI morphometry and lesion-quantification support for qualified healthcare professionals, including segmented overlays, volumetric measurements, normative percentiles and longitudinal comparison.

Modality
MRI
Anatomy
Brain
Decision
2025-09-23
FDA-cleared K243681

Neuro Insight V1.0

Olea Medical S.A.S.

Authorized purpose: Neuro Insight V1.0 assists trained professionals analyzing neurological MRI through NeuroPro maps/metrics and optional Neuro Synchronizer viewing, comparison, and parameter editing in compatible DICOM integration environments; it does not alter original images or replace diagnosis.

Modality
MRI
Anatomy
Brain
Decision
2025-07-23
FDA-cleared K250686

GyriCalc (Version 1.0.0)

NeuroSpectrum Insights Corp.

Authorized purpose: Adjunctive quantitative brain-mapping report for qualified clinical interpretation of children 24-36 months, providing regional volume, surface-area and local-gyrification measures from 3D T1 MRI.

Modality
MRI
Anatomy
Brain
Decision
2025-07-22
FDA-cleared K251009

Cirrus Resting State fMRI Software

Sora Neuroscience, Inc.

Authorized purpose: Cirrus processes MR data, including resting-state BOLD fMRI, to provide task-analogous motor, language, and vision correlation maps in DICOM for external visualization or analysis; the maps are an adjunct and do not replace direct functional mapping.

Modality
MRI
Anatomy
Brain
Decision
2025-06-06
FDA-cleared K250236

Swoop® Portable MR Imaging® System (V2)

Hyperfine, Inc.

Authorized purpose: Swoop Portable MR Imaging System V2 is a portable ultra-low-field MR system for head imaging in adult and pediatric patients, including neonates, at the point of care when a conventional full diagnostic MRI examination is impractical.

Modality
MRI
Anatomy
Brain
Decision
2025-05-30
FDA-cleared K251276

Swoop® Portable MR Imaging® System

Hyperfine, Inc.

Authorized purpose: Swoop Portable MR Imaging System is a portable ultra-low-field MR system for head imaging in adult and pediatric patients at the point of care when conventional full diagnostic MRI is impractical.

Modality
MRI
Anatomy
Brain
Decision
2025-05-21
FDA-cleared K241982

DeepFoqus (DeepFoqus-Accelerate)

Foqus Technologies Inc.

Authorized purpose: DeepFoqus-Accelerate accepts and transfers brain MRI DICOM studies and reconstructs non-contrast sagittal, axial, and coronal T1, T2, and FLAIR images from supported 1.5T and 3T Siemens or GE scanners for adults.

Modality
MRI
Anatomy
Brain
Decision
2025-04-04
FDA-cleared K240712

icobrain aria

icometrix NV

Authorized purpose: Provides concurrent CADe/CADx aid for trained radiologists detecting, assessing, and characterizing ARIA-E and ARIA-H on brain MR images.

Modality
MRI
Anatomy
Brain
Decision
2024-11-07
FDA-cleared K242215

Neurophet AQUA (V3.1)

Neurophet, Inc.

Authorized purpose: Neurophet AQUA is intended for Automatic labeling, visualization and volumetric quantification of segmentable brain structures and lesions from a set of MR images. Volumetric data may be compared to reference percentile data.

Modality
MRI
Anatomy
Brain
Decision
2024-10-25
FDA-cleared K241098

NeuroQuant

CorTechs Labs, Inc.

Authorized purpose: NeuroQuant automatically labels, visualizes, and volumetrically quantifies segmentable brain structures and lesions from MR images, optionally using T2 FLAIR and T2* GRE/SWI for lesion analysis; outputs require radiologist/neuroradiologist review and may be compared with reference percentiles.

Modality
MRI
Anatomy
Brain
Decision
2024-08-22
FDA-cleared K240290

AiMIFY (1.x)

Subtle Medical, Inc.

Authorized purpose: Enhance GBCA-enhanced brain MRI images to improve lesion and tissue contrast for radiologist review while preserving the original post-contrast image context.

Modality
MRI
Anatomy
Brain
Decision
2024-08-21
FDA-cleared K240944

Swoop® Portable MR Imaging® System

Hyperfine, Inc.

Authorized purpose: Swoop Portable MR Imaging System is a portable ultra-low-field MR system for point-of-care head imaging in adult and pediatric patients when a conventional full diagnostic MRI examination is impractical.

Modality
MRI
Anatomy
Brain
Decision
2024-07-16
FDA-cleared K231929

iQ-solutions

Sydney Neuroimaging Analysis Centre Pty Ltd

Authorized purpose: Automatically annotate, visualize, and quantify segmentable brain structures from brain MRI at one time point or longitudinally; longitudinal analysis is limited to the same patient's scans from the same scanner with consistent protocol and contrast at two time points.

Modality
MRI
Anatomy
Brain
Decision
2023-12-18
FDA-cleared K232231

QP-Brain®

Quibim S.L.

Authorized purpose: Automatically label and volumetrically quantify segmentable brain structures and white matter hyperintensities (WMH) from MR images in adults and adolescents aged 18 years and older, as a support tool for properly trained clinicians assessing structural MRIs; patient-management decisions must not rely solely on the device results.

Modality
MRI
Anatomy
Brain
Decision
2023-12-13
FDA-cleared K231642

Veuron-Brain-pAb3

Heuron Co., Ltd.

Authorized purpose: Registration, fusion, display, and quantitative SUVR analysis of brain amyloid PET with MRI support to aid clinician assessment; outputs are reference information, not a stand-alone dementia diagnosis.

Modality
MRI
Anatomy
Brain
Decision
2023-10-13
FDA-cleared K223659

Jazz

AI Medical AG

Authorized purpose: Jazz semi-automatically labels, visualizes, and quantifies segmentable brain structures on MR for patients with known multiple sclerosis and/or brain metastasis, with physician-reviewed/correctable annotations and radiological report output.

Modality
MRI
Anatomy
Brain
Decision
2023-09-22
FDA-cleared K220034

NEUROShield

In-Med Prognostics L3C

Authorized purpose: NEUROShield labels, visualizes, and quantifies hippocampal volume from brain MRI as decision support for neurologists and neuroradiologists.

Modality
MRI
Anatomy
Brain
Decision
2023-09-14
FDA-cleared K223180

AIRAscore

AIRAmed GmbH

Authorized purpose: AIRAscore automatically labels, visualizes and quantifies segmentable brain structures from MR images, replacing manual volume measurement and providing reference-adjusted reports and annotated images for expert physician evaluation.

Modality
MRI
Anatomy
Brain
Decision
2023-08-25
FDA-cleared K230913

ANDI

Imeka Solutions, Inc.

Authorized purpose: ANDI processes diffusion-weighted MRI with auxiliary T1 imaging to create 3D white-matter tract maps and microstructure reports for trained medical professionals as adjunctive measurement information, not diagnosis.

Modality
MRI
Anatomy
Brain
Decision
2023-07-25
FDA-cleared K230552

MR DWI/FLAIR Measurement V1.0

Olea Medical

Authorized purpose: MR DWI/FLAIR Measurement V1.0 processes brain DWI and FLAIR MRI to calculate ADC maps, segment ADC-hypointense regions, and communicate relative or normalized FLAIR measurements; it is an adjunct and cannot be used alone for diagnosis, treatment, or patient-management decisions.

Modality
MRI
Anatomy
Brain
Decision
2023-04-26
FDA-cleared K223268

BrainInsight

Hyperfine, Inc.

Authorized purpose: Automatically labels, measures, and quantifies brain structures from specified low-field MR images.

Modality
MRI
Anatomy
Brain
Decision
2022-12-16
FDA-cleared K220815

BrainInsight

Hyperfine, Inc.

Authorized purpose: Automatically labels, spatially measures, and volumetrically quantifies brain structures from low-field MR images and returns annotated/segmented images, color overlays, and reports.

Modality
MRI
Anatomy
Brain
Decision
2022-07-19
FDA-cleared K213706

AI-Rad Companion Brain MR

Siemens Healthcare GmBh

Authorized purpose: AI-Rad Companion Brain MR VA40 post-processes head MR images to segment and quantify brain structures and white-matter hyperintensities, compare normalized values with healthy reference data, and return visual and numeric reports for clinician review.

Modality
MRI
Anatomy
Brain
Decision
2022-04-15
FDA-cleared K213628

VBrain

Vysioneer Inc.

Authorized purpose: VBrain assists trained professionals in radiation-treatment planning by generating initial contours of known or diagnosed adult brain metastases, meningiomas, or acoustic neuromas and organs at risk from axial T1 contrast-enhanced brain MRI; contours must be finalized on an external DICOM-RT platform.

Modality
MRI
Anatomy
Brain
Decision
2021-12-16
FDA-cleared K193287

CorInsights MRI

ADM Diagnostics, Inc.

Authorized purpose: Automatically labels, visualizes, and volumetrically quantifies segmentable brain structures from MR images with reference-percentile comparison for adults age 45-95.

Modality
MRI
Anatomy
Brain
Decision
2020-11-20
FDA-cleared K193290

AI-Rad Companion Brain MR

Siemens Medical Solutions USA, Inc.

Authorized purpose: AI-Rad Companion Brain MR post-processes typical head-MR T1 MPRAGE images to automatically segment and quantify brain structures, compare normalized volumes with healthy reference data, and present numeric and visual reporting information to clinicians.

Modality
MRI
Anatomy
Brain
Decision
2020-06-17
FDA-cleared K192130

Icobrain

Icometrix NV

icobrain is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR or NCCT images. This software is intended to automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR or NCCT images. icobrain consists of two distinct image processing pipelines: icobrain cross and icobrain long.

Modality
MRI
Anatomy
Brain
Decision
2019-12-13
FDA-cleared K182564

Quantib ND

Quantib BV

Authorized purpose: Quantib ND is software for the labeled brain MRI image-analysis workflow, providing release-specific visualization, measurements, or decision-support outputs for professional review.

Modality
MRI
Anatomy
Brain
Decision
2018-12-27
FDA-cleared K171328

cNeuro cMRI

Combinostics Oy

Authorized purpose: Automatically labels, quantifies, and visualizes segmentable brain structures from MR images.

Modality
MRI
Anatomy
Brain
Decision
2018-01-08
FDA-cleared K170981

NeuroQuant

CorTechs Labs, Inc

Authorized purpose: NeuroQuant is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures and lesions from a set of MR images.

Modality
MRI
Anatomy
Brain
Decision
2017-09-07
FDA-cleared K162830

SIS Software

Surgical Information Sciences, Inc.

Authorized purpose: SIS Software fuses brain MRI with postoperative CT to visualize and localize the subthalamic nucleus for stereotactic neurosurgical planning.

Modality
MRI
Anatomy
Brain
Decision
2017-02-14
FDA-cleared K161148

icobrain

Icometrix

Authorized purpose: icobrain segments and quantifies brain structures and lesions from T1-weighted and FLAIR MRI using cross-sectional and longitudinal workflows with acquisition-consistency limits.

Modality
MRI
Anatomy
Brain
Decision
2016-08-09
FDA-cleared K080762

IB NEURO, VERSION 1.0

IMAGING BIOMETRICS, LLC

Authorized purpose: Post-processing of dynamic brain MRI to generate perfusion maps for trained-physician interpretation.

Modality
MRI
Anatomy
Brain
Decision
2008-05-15